Search
for

    Sort by

    Research 421–450 of 1000+

    1. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    2. Treatment of severe alopecia areata with baricitinib JAAD Case Reports · 2019 · 25 citations
    3. A Case of Cicatricial Alopecia Associated with Erlotinib Annals of Dermatology · 2011 · 25 citations
    4. Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes JAAD Case Reports · 2018 · 24 citations
    5. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman Acta dermato-venereologica · 2016 · 24 citations
    6. Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats. PubMed · 2016 · 24 citations
    7. Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata JAMA Dermatology · 2022 · 23 citations
    8. Baicalin increases hair follicle development by increasing canonical Wnt/β‑catenin signaling and activating dermal papillar cells in mice International Journal of Molecular Medicine · 2018 · 23 citations
    9. Lack of efficacy of apremilast in 9 patients with severe alopecia areata Journal of the American Academy of Dermatology · 2017 · 23 citations
    10. Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient Skin appendage disorders · 2017 · 22 citations
    11. The Metabolism and Control Mechanism of Human Hair Follicles Current problems in dermatology · 2015 · 22 citations
    12. Current Treatments for Alopecia Areata 2015 · 21 citations
    13. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    14. Emerging drugs for alopecia areata: JAK inhibitors Expert opinion on emerging drugs · 2018 · 20 citations
    15. Novedades terapéuticas en tricología Actas Dermo-Sifiliográficas · 2017 · 20 citations
    16. The role of oclacitinib in the management of ischaemic dermatopathy in four dogs Veterinary dermatology · 2019 · 19 citations
    17. Treatments options for alopecia Expert Opinion on Pharmacotherapy · 2015 · 17 citations
    18. Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series Rheumatology and Therapy · 2017 · 16 citations
    19. Excellent response to tofacitinib treatment in a patient with alopecia universalis Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2017 · 16 citations
    20. Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma Clinical Cancer Research · 2015 · 16 citations
    21. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen European Journal of Dermatology · 2019 · 15 citations
    22. Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review Acta Dermato Venereologica · 2023 · 14 citations
    23. Reversal of Alopecia Universalis by Tofacitinib: A Case Report Annals of Internal Medicine · 2016 · 14 citations
    24. Rethinking the classification of alopecia areata Journal of the American Academy of Dermatology · 2018 · 13 citations
    25. Alopecia in general medicine Clinical Medicine · 2016 · 13 citations
    26. Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system Expert Opinion on Drug Discovery · 2024 · 12 citations
    27. Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report Journal of the European Academy of Dermatology and Venereology · 2023 · 12 citations
    28. New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata Dermatologic Therapy · 2022 · 12 citations
    29. A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib JAAD case reports · 2022 · 11 citations
    30. An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature Clinical Case Reports · 2019 · 11 citations